| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (miscellaneous) | 57 / 466 | 87th | Q1 |
| Biochemistry, Genetics and Molecular Biology (all) | 39 / 223 | 82nd | Q1 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Biomedicines
Biomedicines is Scopus-indexed (Q1, CiteScore 7.8), WoS SCIE, DOAJ. Published by Multidisciplinary Digital Publishing Institute (MDPI).
Checked against the index lists dated .
ISSN 2227-9059Verify ISSN ↗
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
Cost to publish: Checking DOAJ for article charges…
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Biomedicines indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2013–present, best quartile Q1, CiteScore 7.8.
What quartile is Biomedicines in Scopus?
Biomedicines is Q1 in Medicine (miscellaneous) (rank 57 of 466) and Q1 in Biochemistry, Genetics and Molecular Biology (all) (rank 39 of 223), by CiteScore 2025.
What is the impact factor of Biomedicines?
Biomedicines is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7.8, which places it in quartile Q1 at the 87th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.165, quartile Q1, with an H-index of 108.
How much does it cost to publish in Biomedicines?
The publisher lists an article processing charge of about US$3,137 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes Biomedicines and what is its ISSN?
Biomedicines is published by Multidisciplinary Digital Publishing Institute (MDPI). Its ISSN is 2227-9059.
Is Biomedicines in Web of Science?
Yes — indexed in the Science Citation Index Expanded.
Is Biomedicines open access?
Yes — it is an open-access journal, listed in DOAJ.
How well cited is Biomedicines? — open metrics via OpenAlex
Biomedicines has an h-index of 133 and a 2-year mean of 5.11 citations per paper (OpenAlex). Its Scopus CiteScore is 7.8, quartile Q1. On 2-year citations it ranks #44 of 451 Scopus journals in Medicine (miscellaneous).
Biomedicines published 3,135 papers in 2025; its busiest recent year was 2023 with 3,330. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Biomedicines? — latest 99 articles, 2026
In its latest 99 research articles (2026), authors are most often from China (24.2%), Türkiye (8.9%) and United States (8.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Biomedicines? — indicators, not proof of misconduct
Scopus status: Active. 24 retracted papers are recorded (1.3 per 1,000 papers). The Problematic Paper Screener flags 3 of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers 24 · 1.3 per 1,000 papers
- Problematic Paper Screener flags 3 · 0.2 per 1,000 papers — mostly tortured phrases and suspect text
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.